Can you provide the last earnings date for Avadel Pharmaceuticals PLC?
Avadel Pharmaceuticals PLC (AVDL) last reported earnings on 11/4/2025.
Avadel Pharmaceuticals PLC (AVDL) Earnings History & Surprises
NASDAQ:AVDL • IE00BDGMC594
Current stock price
21.64 USD
+0.01 (+0.05%)
At close:
21.65 USD
+0.01 (+0.05%)
After Hours:
AVDL Earnings overview
Past quarterly earnings results for Avadel Pharmaceuticals PLC (AVDL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 9, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.09
- Revenue Estimate
- 80.251M
Last Reported
Most Recent- Release Date
- Nov 4, 2025
- Period
- Q3 / 2025
- EPS Reported
- $0.00
- EPS Surprise
- -100.00%
- Revenue Surprise
- 3.23%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.00 | 0.07 | -100.00% | 100.00% | 77.467M | 75.045M | 3.23% | 54.86% |
| Q2 2025 | 0.10 | 0.03 | 258.07% | 171.43% | 68.129M | 62.728M | 8.61% | 64.15% |
| Q1 2025 | -0.05 | -0.07 | 31.20% | 83.33% | 52.511M | 51.724M | 1.52% | 93.21% |
| Q4 2024 | -0.05 | -0.04 | -20.15% | 82.76% | 50.41M | 51.034M | -1.22% | 159.14% |
| Q3 2024 | -0.03 | -0.06 | 46.72% | 92.68% | 50.025M | 49.579M | 0.90% | 613.22% |
| Q2 2024 | -0.14 | -0.16 | 11.79% | 83.13% | 41.504M | 38.285M | 8.41% | 2,674.33% |
| Q1 2024 | -0.30 | -0.21 | -41.55% | 37.50% | 27.178M | 26.416M | 2.88% | - |
| Q4 2023 | -0.29 | -0.26 | -9.63% | 36.96% | 19.453M | 18.574M | 4.73% | - |
| Q3 2023 | -0.41 | -0.38 | -7.98% | -24.24% | 7.014M | 5.19M | 35.14% | - |
| Q2 2023 | -0.83 | -0.39 | -111.75% | 17.82% | 1.496M | 643.763K | 132.38% | - |
| Q1 2023 | -0.48 | -0.38 | -24.86% | -6.67% | - | - | ||
| Q4 2022 | -0.46 | -0.28 | -66.41% | -21.05% | - | - | ||
| Q3 2022 | -0.33 | -0.26 | -27.71% | 13.16% | - | - | ||
| Q2 2022 | -1.01 | -0.42 | -141.71% | -206.06% | - | - | ||
| Q1 2022 | -0.45 | -0.44 | -2.01% | -95.65% | - | - | ||
| Q4 2021 | -0.38 | -0.42 | 10.01% | -100.00% | - | - | ||
| Q3 2021 | -0.38 | -0.39 | 3.23% | -90.00% | - | - | ||
| Q2 2021 | -0.33 | -0.32 | -2.89% | -120.00% | - | -100.00% | ||
| Q1 2021 | -0.23 | -0.32 | 29.04% | -1,050.00% | - | -100.00% | ||
| Q4 2020 | -0.19 | -0.28 | 31.29% | - | - | - | ||
| Q3 2020 | -0.20 | -0.26 | 21.96% | - | - | - | ||
| Q2 2020 | -0.15 | -0.10 | -52.79% | - | 10.091M | 7.516M | 34.26% | - |
| Q1 2020 | -0.02 | -0.24 | 91.76% | - | 12.243M | 10.353M | 18.26% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
42.28%
Max EPS beat (4)
258.07%
Min EPS beat (4)
-100.00%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
3.03%
Max Revenue beat (4)
8.61%
Min Revenue beat (4)
-1.22%
Analysis
In the last 4 quarters, AVDL has beaten EPS estimates in 2 out of 4 releases
AVDL has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AVDL has beaten the EPS estimates by 42.3% on average.
In the last 4 quarters, AVDL has beaten the revenue estimates by 3.0% on average.
Related analysis
Avadel Pharmaceuticals PLC / AVDL Earnings FAQ
Did AVDL stock beat earnings estimates in the most recent quarter?
Avadel Pharmaceuticals PLC (AVDL) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often Avadel Pharmaceuticals PLC beats earnings estimates?
In the last 4 quarters, Avadel Pharmaceuticals PLC (AVDL) has beaten EPS estimates in 2 out of 4 releases.